Veracyte Analyst Price Targets - Benzinga

Veracyte Inc

VCYTNASDAQ

Trade with Public

Trade with Public

$43.48

-0.54-1.22%

Ult. Agg.: Oct 13, 2:56 PM

$44.29

0.270.61%

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Opzioni Rapporto azionario

Veracyte Analyst Price Targets - Benzinga

Veracyte Analyst Price Targets

Wall Street analyst price targets and consensus rating for Veracyte (VCYT).

Price Target Range — 11 Quarters

Analyst Consensus — 12 Analysts

9Buy

2Hold

1Sell

Consensus RatingBuy# Analysts12Avg. Consensus PT$52Upside to Avg. PT+20.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 15, 2026	Freedom Capital Markets	Keith Hinton	Maintained	Buy	$66
Sep 9, 2026	UBS	Doug Schenkel	PT Raise	Buy	$52→$65
Aug 4, 2026	Piper Sandler	David Westenberg	PT Cut	Overweight	$66→$54
Aug 4, 2026	Stephens & Co.	Mason Carrico	PT Cut	Overweight	$68→$55
Aug 4, 2026	Morgan Stanley	Tejas Savant	PT Cut	Underweight	$47→$44
Aug 3, 2026	Canaccord Genuity	Kyle Mikson	PT Cut	Hold	$60→$50
Jul 31, 2026	Needham	Mike Matson	PT Raise	Buy	$57→$69
Jul 30, 2026	Needham	Mike Matson	PT Raise	Buy	$57→$69
Jul 15, 2026	Piper Sandler	David Westenberg	Initiate	Overweight	$66
Jul 14, 2026	Canaccord Genuity	Kyle Mikson	PT Raise	Hold	$42→$60
Jul 9, 2026	Morgan Stanley	Tejas Savant	PT Raise	Underweight	$37→$47
Jun 29, 2026	Guggenheim	Subbu Nambi	PT Raise	Buy	$45→$65
Jun 1, 2026	Needham	Mike Matson	PT Raise	Buy	$48→$57
May 28, 2026	Needham	Mike Matson	Maintained	Buy	$48
May 6, 2026	Canaccord Genuity	Kyle Mikson	PT Raise	Hold	$40→$42
May 6, 2026	UBS	Lu Li	PT Raise	Buy	$48→$52
Apr 20, 2026	Canaccord Genuity	Kyle Mikson	PT Cut	Hold	$43→$40
Apr 13, 2026	Jefferies	Tycho Peterson	Initiate	Buy	$45
Apr 1, 2026	Needham	Mike Matson	Maintained	Buy	$48
Mar 30, 2026	Guggenheim	Subbu Nambi	PT Cut	Buy	$50→$45

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
UBS Maintains Buy on Veracyte, Raises Price Target to $65

UBS analyst Doug Schenkel maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $52 to $65.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Overweight on Veracyte, Lowers Price Target to $54

Piper Sandler analyst David Westenberg maintains Veracyte (NASDAQ:VCYT) with a Overweight and lowers the price target from $66 to $54.

Benzinga Newsdesk

PRO
Stephens & Co. Maintains Overweight on Veracyte, Lowers Price Target to $55

Stephens & Co. analyst Mason Carrico maintains Veracyte (NASDAQ:VCYT) with a Overweight and lowers the price target from $68 to $55.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Underweight on Veracyte, Lowers Price Target to $44

Morgan Stanley analyst Tejas Savant maintains Veracyte (NASDAQ:VCYT) with a Underweight and lowers the price target from $47 to $44.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Hold on Veracyte, Lowers Price Target to $50

Canaccord Genuity analyst Kyle Mikson maintains Veracyte (NASDAQ:VCYT) with a Hold and lowers the price target from $60 to $50.

Benzinga Newsdesk

PRO
Needham Maintains Buy on Veracyte, Raises Price Target to $69

Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $57 to $69.

Benzinga Newsdesk